Biophytis SA BPTS:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/05/22 EDT
1.12quote price arrow down-0.15 (-12.07%)
Volume
19,911
52 week range
0.81 - 9.60
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.12
  • 52 Week High9.60
  • 52 Week High Date09/02/21
  • 52 Week Low0.81
  • 52 Week Low Date07/20/22

Key Stats

  • Market Cap18.35M
  • Shares Out16.38M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-79.03

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.12
  • 52 Week High9.60
  • 52 Week High Date09/02/21
  • 52 Week Low0.81
  • 52 Week Low Date07/20/22
  • Market Cap18.35M
  • Shares Out16.38M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-79.03

RATIOS/PROFITABILITY

  • EPS (TTM)-2.99
  • P/E (TTM)-0.38
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-27.149M
  • ROE (TTM)-777.65%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)268.01%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biophytis SA

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201)...
Stanislas Veillet
Chairman of the Board, Chief Executive Officer
Waly Dioh Ph.D.
Chief Clinical Operating Officer
Philippe Rousseau
Chief Financial Officer
Address
14 avenue de l'Opera
Paris
75001
France